DexCom, Inc.'s growth is impressive but limited by its niche market, with my projected ceiling being ~$7.5bn in peak annual revenues. Despite positive Q4 2024 results, DexCom's stock is fairly valued, ...
Visit a quote page and your recently viewed tickers will be displayed here. Mr. Donald M. Abbey is an Independent Director at ICU Medical, Inc. and an Executive VP-IT, Quality & Regulatory Affairs at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback